Alembic Pharma announces seed round investment in in RIGImmune
RIGImmune will utilise the proceeds of the series seed round to further the development of therapeutic oligonucleotides
Source: biospectrumindia.com
Stay updated with breaking news from Anna Pyle. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
RIGImmune will utilise the proceeds of the series seed round to further the development of therapeutic oligonucleotides